Fulcrum Therapeutics (FULC) Depreciation and Depletion (2018 - 2026)
Fulcrum Therapeutics' (FULC) quarterly Depreciation and Depletion came in at $300000.0 in Q1 2026, down 25.0% year-on-year from $400000.0 in Q1 2025, and down 25.0% on a QoQ basis from $400000.0 in Q4 2025.
Fulcrum Therapeutics (FULC) Depreciation and Depletion (2018 - 2026) Analysis & Trends
Fulcrum Therapeutics (FULC) has 9 years of Depreciation and Depletion data on file, last reported at $300000.0 in Q1 2026.
- On a quarterly basis, Depreciation and Depletion fell 25.0% year-over-year to $300000.0 in Q1 2026; TTM through Mar 2026 was $1.3 million, a 18.75% decrease from a year earlier, with the FY2025 full-year figure at $1.4 million, down 12.5% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $300000.0, down from $400000.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for FULC reached as high as $700000.0 in Q2 2022 and fell as low as $300000.0 in Q2 2025.
- Historically, Depreciation and Depletion has averaged $470941.2 across 5 years, with a median of $479000.0 in 2024.
- Across the five-year window, Depreciation and Depletion increased 20.0% in 2023 and slumped 33.33% in 2024, its largest moves.
- Year by year, Depreciation and Depletion stood at $591000.0 in 2022, then fell by 9.31% to $536000.0 in 2023, then decreased by 25.37% to $400000.0 in 2024, then changed by 0.0% to $400000.0 in 2025, then slipped by 25.0% to $300000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation and Depletion figures were $300000.0 in Q1 2026, $400000.0 in Q4 2025, and $300000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,899.87 Bn | 1,899.81 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.43 Bn | 465.64 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 123.43 Bn | 116.19 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.20 Bn | 61.44 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.75 Bn | 61.75 Bn | - | - |
| 8 | Argenx Se | 56.15 Bn | 50.96 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn | - |
| 10 | Fulcrum Therapeutics | 283.90 Mn | 283.90 Mn | - | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 400,000.00 |
| Dec 31, 2024 | 400,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Mar 31, 2024 | 479,000.00 |
| Mar 31, 2024 | 479,000.00 |
| Dec 31, 2023 | 536,000.00 |
| Dec 31, 2023 | 536,000.00 |